Savillex completes acquisition of Entegris life sciences fluid management business

The transaction adds Aramus and PE bags, single-use assemblies and components for bioprocessing and pharmaceutical manufacturing to Savillex's portfolio.

Savillex LLC, based in Eden Prairie, Minn., has completed its acquisition of Entegris Inc.'s Life Sciences Fluid Management business, the company announced. The purchased business, based in Billerica, Mass., supplies bioprocessing and pharmaceutical manufacturing products, including Aramus and PE bags, single-use assemblies and components used in discovery, clinical and commercial manufacturing. Financial terms were not disclosed.

Savillex described itself as a provider of high-purity fluid handling solutions for life science and laboratory applications worldwide. It said the acquisition broadens its life sciences offerings with a larger portfolio of high-performance single-use products. Customers can expect expanded single-use solutions, additional technical expertise and enhanced capabilities for applications from early-stage research through commercial manufacturing, according to the company. Savillex said combining the complementary strengths of the two businesses positions it to deliver greater value and help customers simplify increasingly complex bioprocessing workflows.

Portfolio and leadership comments

Chief Executive Officer Eric Giesing said the acquired business has built a strong reputation in high-purity single-use bioprocessing and that the Aramus product line is a natural fit alongside Savillex's Savillex, Containment and Bioprocessing offerings. He said the transaction expands the company's portfolio and enables it to offer a broader range of innovative solutions to biopharmaceutical and pharmaceutical customers. Giesing also said Savillex welcomes the team behind the business and will continue investing in technologies that help customers accelerate development and production of critical therapies.

Chris Bedi, general manager of Fluid Management at Savillex, said the acquisition creates an opportunity to bring a broader portfolio of high-value fluid management solutions to pharmaceutical and biopharmaceutical customers worldwide. He said the acquired portfolio complements Savillex's existing capabilities and that the combined organization will continue to provide innovative solutions while expanding its ability to support partners across drug development. Bedi said the company is excited by the opportunity to help customers bring new medicines to patients.

Strategy and advisers

Savillex said the acquisition advances its strategy of delivering industry-leading solutions for the life sciences market. The company said it remains committed to investing in innovation, quality and customer partnerships while expanding its portfolio to meet the evolving needs of biopharmaceutical and pharmaceutical manufacturers. It said the acquired business brings an experienced Life Sciences Fluid Management team and proven technologies in high-purity fluid management.

EC M&A in New York served as financial adviser to Savillex, and Sidley Austin LLP in Chicago served as legal counsel. Savillex did not disclose the terms of the transaction.

LF

Luciana Ferreira

Luciana Ferreira covers sustainable specification, material substitution, and lifecycle planning across roofing, insulation, fenestration, flooring, and cladding product families. Her analysis works from NFRC-rated fenestration U-factor and solar heat-gain values where those ratings apply, insulation R-value and assembly U-value with stated boundary conditions, and documented maintenance intervals and lifecycle cost assumptions. She helps specification writers, developers, and facility managers decide when a substitution, retrofit sequence, or documentation request is justified before a project commitment.